The Source for Whistleblowers, Journalists, Legislators & Academics

High Court sides with generic drug makers in narrow ruling – 06/23/11

The Supreme Court issued a troubling decision that stands as a direct threat to consumer protection within the pharmaceutical industry.  The Court determined that generic drug companies do not share the same level of responsibility as makers of brand-name equivalents, to update their warning labels when significant new risks emerge.  Generic drugs now account for more than 70% of prescriptions filled in the U.S.  The Court’s decision to shield generic drug companies from liability goes against precedent and public policy.

Read more:  http://www.cnn.com/2011/HEALTH/06/23/scotus.generic.drugs/index.html

Related posts

Democracy Misconceived

By William Nettles and Reuben Guttman There is a misconception among many that democracy...

The Art of Advocacy

Judges are now insisting that plaintiffs make their case with facts instead of merely...

Rapamune In the News

The Justice Department on Tuesday joined a whistleblower lawsuit against Pfizer and its subsidiary...

Comments are currently closed.

Top